Important note: Information in this article was accurate in 2003. The state of the art may have changed since the publication date.
Mail & Guardian (Johannesburg) - Thursday October 23, 2003
New drug: A flexible new anti-Aids drug, Lexiva, has been approved by the United States's Food and Drug Administration.
Lexiva, launched by GlaxoSmithKline, is part of a class of drugs known as protease inhibitors that have been manufactured to increase compliance with the drugs. It is said to offer more flexible dosing than similar medicines. According to Glaxo, there are no food and water restrictions, and the two-pill dose can be taken once or twice daily. Other drugs are taken up to eight times daily.
"It's important for patients to comply with therapy because current treatment is lifelong," said Professor Jeffrey P Nadler of the University of South Florida College Of Medicine. "Patients need something they can tolerate, so they are able to take the medicines as prescribed. Lexiva fits that picture."
Glaxo says the drug's safety and effectiveness was demonstrated in clinical trials involving more than 1 200 people.
031023
MG031012
Copyright © 2003 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2003. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2003. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .